Carriage of cytochrome 2C19 polymorphism is associated with risk of high post-treatment platelet reactivity on high maintenance-dose clopidogrel of 150 mg/day: results of the ACCEL-DOUBLE (Accelerated Platelet Inhibition by a Double Dose of Clopidogrel According to Gene Polymorphism) study

JACC. Cardiovascular Interventions
Young-Hoon JeongJin-Yong Hwang

Abstract

This study sought to determine the impact of gene polymorphisms on platelet reactivity (PR) after clopidogrel 150 mg/day in patients treated with percutaneous coronary intervention (PCI). Although high maintenance-dose (MD) clopidogrel reduces PR, it is unknown whether gene polymorphisms are related with the risk of high post-treatment PR (HPPR) after high-MD clopidogrel. We included mostly patients receiving high-MD clopidogrel after PCI from previously registered Gyeongsang National University Hospital data. A total of 126 PCI-treated patients receiving high-MD clopidogrel were enrolled. Platelet reactivity was assessed with conventional aggregometry and VerifyNow (Accumetrics Inc., San Diego, California) after receiving clopidogrel 150 mg/day for at least 1 month. CYP3A5, CYP2C19, and ABCB1 genotyping was performed. We defined HPPR as 5 micromol/l adenosine diphosphate (ADP)-induced maximal PR (PR(max)) >50%. CYP3A5 and ABCB1 polymorphisms did not influence PR. Carriers of CYP2C19 variant (*2 or *3) (n = 80) had significantly higher 5 and 20 micromol/l ADP-induced PR(max) than did noncarriers (n = 46) (40.7 +/- 16.8% vs. 30.3 +/- 12.6%, p < 0.001; 54.2 +/- 16.2% vs. 40.5 +/- 15.8%, p < 0.001, respectively). Late PR and Verif...Continue Reading

Citations

Aug 9, 2011·Drug Metabolism and Drug Interactions·Sandra L Close
Jan 18, 2018·Expert Opinion on Drug Metabolism & Toxicology·Danny Kupka, Dirk Sibbing
Oct 31, 2019·Clinical and Translational Science·Brittney H DavisShuko Harada
Mar 3, 2012·Current Opinion in Cardiology·Quinn S WellsDan M Roden
Oct 4, 2012·Expert Review of Cardiovascular Therapy·Mark J AntoninoPaul A Gurbel
Apr 12, 2011·Thrombosis and Haemostasis·Liana YukhanyanKurt Huber
Sep 11, 2013·Therapeutic Advances in Drug Safety·Jivan Moaddeb, Susanne B Haga
Jul 28, 2011·Thrombosis and Haemostasis·Paul Fefer, Shlomi Matetzky
Oct 24, 2014·Expert Review of Cardiovascular Therapy·Sahar IsmailAmer K Ardati
Aug 16, 2017·Journal of Community Hospital Internal Medicine Perspectives·Seyed Abbas MirabbasiGang Cheng
Jan 13, 2012·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Charles M StromWeimin Sun
Apr 30, 2015·Diabetes & Metabolism Journal·Jung Hwa JungYoung-Hoon Jeong
Jun 7, 2012·The Annals of Pharmacotherapy·Kelly C RogersShannon W Finks
Sep 2, 2011·Fundamental & Clinical Pharmacology·Sandra L Close
Jun 2, 2011·Future Cardiology·Antonio Tello-MontoliuDominick J Angiolillo
Jul 13, 2012·Expert Opinion on Pharmacotherapy·Young-Hoon JeongPaul A Gurbel
Oct 20, 2011·Circulation. Cardiovascular Interventions·Guillaume ParéAdnan Kastrati
May 2, 2021·Expert Opinion on Drug Metabolism & Toxicology·Abdullah Alkattan, Eman Alsalameen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.